XML 28 R4.htm IDEA: XBRL DOCUMENT v3.6.0.2
CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($)
$ in Millions
3 Months Ended 12 Months Ended
Mar. 31, 2014
Dec. 31, 2016
Dec. 31, 2015
Interest expense $ (109.5) $ (219.1) $ (274.9)
Operating income 904.3 1,312.4 996.8
Net sales 6,011.6 9,437.2 8,505.7
Reimbursement Revenue 0.0 204.6 174.4
Revenues 6,011.6 9,641.8 8,680.1
Cost of sales 3,808.5 6,256.7 5,602.4
Cost of Reimbursable Expense 0.0 204.6 174.4
Cost of Revenue 3,808.5 6,461.3 5,776.8
Gross profit 2,203.1 3,180.5 2,903.3
Selling, general and administrative expenses 1,204.3 1,630.2 1,628.1
Amortization of intangibles and other assets 76.7 179.5 164.5
Restructuring and other special charges 17.8 58.4 113.9
Equity method income, net 14.3 7.9 10.0
Investment income 1.1 1.7 1.9
Other, net 10.4 2.6 (7.8)
Earnings before income taxes 820.6 1,105.5 726.0
Provision for income taxes 308.0 372.3 287.3
Net earnings 512.6 733.2 438.7
Less: Net earnings attributable to the noncontrolling interest 1.4 1.1 1.1
Net earnings attributable to Laboratory Corporation of America Holdings $ 511.2 $ 732.1 $ 437.6